The PE Ratio as of November 2024 (TTM) for Enzon Pharmaceuticals, Inc. (ENZN) is 8.00

According to Enzon Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 8.00. This represents a change of 11.21% compared to the average of 7.19 of the last 4 quarters.

Enzon Pharmaceuticals, Inc. (ENZN) Historical PE Ratio (quarterly & annually)

How has ENZN PE Ratio performed in the past?

The mean historical PE Ratio of Enzon Pharmaceuticals, Inc. over the last ten years is -10.79. The current 8.00 PE Ratio has changed -7514.45% with respect to the historical average. Over the past ten years (40 quarters), ENZN's PE Ratio was at its highest in in the March 2021 quarter at 1.37K. The PE Ratio was at its lowest in in the June 2021 quarter at -644.50.

Enzon Pharmaceuticals, Inc. (ENZN) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Enzon Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Enzon Pharmaceuticals, Inc. (ENZN) Average PE Ratio

How has ENZN PE Ratio performed in the past?

The current PE Ratio of Enzon Pharmaceuticals, Inc. (ENZN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Enzon Pharmaceuticals, Inc. (ENZN) PE Ratio vs. Peers

How is ENZN’s PE Ratio compared to its peers?

Enzon Pharmaceuticals, Inc.’s PE Ratio is greater than PMV Pharmaceuticals, Inc. (-1.61), greater than NewAmsterdam Pharma Company N.V. (-10.06), greater than Tempest Therapeutics, Inc. (-0.66), greater than IO Biotech, Inc. (-0.52), less than Molecular Pharmacology (USA), Ltd. (0), greater than Curative Biotechnology, Inc. (-1.76), less than Kineta, Inc. (0), greater than OncoVista Innovative Therapies, Inc. (-0.36), less than Neurobiological Technologies, Inc. (0), less than Polydex Pharmaceuticals Limited (0), less than Cyclacel Pharmaceuticals, Inc. (0), greater than Living Cell Technologies Limited (0), greater than MultiCell Technologies, Inc. (-0.07), greater than Institute of Biomedical Research Corp. (-3.68), greater than Health Sciences Group, Inc. (-0.10), greater than Mymetics Corporation (-0.21), less than Eliem Therapeutics, Inc. (0), greater than Molecular Partners AG (-0.00), greater than Opthea Limited (-2.42), greater than PureTech Health plc (-2.50), greater than Acrivon Therapeutics, Inc. Common Stock (-1.15), greater than null (-59.33), greater than null (-3.24),

Build a custom stock screener for Enzon Pharmaceuticals, Inc. (ENZN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Enzon Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Enzon Pharmaceuticals, Inc. (ENZN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Enzon Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.